UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.123

Sortiert nach

Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells

Drug metabolism and disposition, 1996-06, Vol.24 (6), p.634

1996

Volltextzugriff (PDF)

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s

Drug metabolism and disposition, 1997-10, Vol.25 (10), p.1191

1997

Volltextzugriff (PDF)

The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs

Drug metabolism and disposition, 2000-10, Vol.28 (10), p.1244

2000

Volltextzugriff (PDF)

Ethambutol Toxicity in HIV Patients on Antiretroviral Therapy

RUHS journal of health sciences, 2023-10, Vol.2 (4), p.207

2023

Volltextzugriff (PDF)

Disseminated lymphangiomatosis presenting with massive chylothorax

Pediatric radiology, 2000-01, Vol.30 (1), p.35-37

2000

Volltextzugriff (PDF)

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies

The Journal of pharmacology and experimental therapeutics, 1991-06, Vol.257 (3), p.1225

1991

Volltextzugriff (PDF)

Pharmacokinetics of Intravenous Alendronate

Journal of clinical pharmacology, 1999-04, Vol.39 (4), p.385-393

1999

Volltextzugriff (PDF)

Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques

Drug metabolism and disposition, 2001-12, Vol.29 (12), p.1614

2001

Volltextzugriff (PDF)

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans

Drug metabolism and disposition, 2000-01, Vol.28 (1), p.89

2000

Volltextzugriff (PDF)

Mesenchymal hamartoma of the liver

Computerized medical imaging and graphics, 2001, Vol.25 (1), p.61-65

2001

Volltextzugriff (PDF)

Type IV choledochal cyst presenting with obstructive jaundice: role of MR cholangiopancreatography in preoperative evaluation

American journal of roentgenology (1976), 1998-08, Vol.171 (2), p.457

1998

Volltextzugriff (PDF)

In vitro and in vivo studies on the metabolism of tirofiban

Drug metabolism and disposition, 1999-11, Vol.27 (11), p.1360

1999

Volltextzugriff (PDF)

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase

Drug metabolism and disposition, 1990-07, Vol.18 (4), p.476

1990

Volltextzugriff (PDF)

Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2000-01, Vol.40 (1), p.74-83

2000

Volltextzugriff (PDF)

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human

Drug metabolism and disposition, 1993-11, Vol.21 (6), p.1003

1993

Volltextzugriff (PDF)

Disposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee

Drug metabolism and disposition, 1995-10, Vol.23 (10), p.1104

1995

Volltextzugriff (PDF)

Malignant pleural mesothelioma in a 13-year-old girl

Pediatric radiology, 2000-11, Vol.30 (11), p.776-778

2000

Volltextzugriff (PDF)

Melanotic Schwannoma Mimicking Myositis Ossificans

Clinical nuclear medicine, 2000-03, Vol.25 (3), p.209-209

2000

Volltextzugriff (PDF)

Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs

Drug metabolism and disposition, 1998-05, Vol.26 (5), p.388

1998

Volltextzugriff (PDF)

Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics

Drug metabolism and disposition, 1997-03, Vol.25 (3), p.355

1997

Volltextzugriff (PDF)

In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate

Drug metabolism and disposition, 1997-08, Vol.25 (8), p.978

1997

Volltextzugriff (PDF)

Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin

Drug metabolism and disposition, 1990-03, Vol.18 (2), p.218

1990

Volltextzugriff (PDF)

Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs

Drug metabolism and disposition, 1994-07, Vol.22 (4), p.631

1994

Volltextzugriff (PDF)

Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol

British journal of clinical pharmacology, 2001-07, Vol.52 (1), p.69-76

2001

Volltextzugriff (PDF)

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse

Drug metabolism and disposition, 1990-03, Vol.18 (2), p.203

1990

Volltextzugriff (PDF)

1 – 25 von 1.123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(907)
Mit Volltextzugriff
(898)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s

The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs

Ethambutol Toxicity in HIV Patients on Antiretroviral Therapy

Disseminated lymphangiomatosis presenting with massive chylothorax

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies

Pharmacokinetics of Intravenous Alendronate

Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans

Mesenchymal hamartoma of the liver

Type IV choledochal cyst presenting with obstructive jaundice: role of MR cholangiopancreatography in preoperative evaluation

In vitro and in vivo studies on the metabolism of tirofiban

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase

Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human

Disposition of DMP 811 (L-708,404), a potent angiotensin II receptor antagonist, in the rat, monkey, and chimpanzee

Malignant pleural mesothelioma in a 13-year-old girl

Melanotic Schwannoma Mimicking Myositis Ossificans

Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs

Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics

In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate

Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin

Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs

Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse

Suchergebnisse filtern